Incyte to Present at Upcoming Investor Conferences
- Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference on Tuesday, June 10, 2008 at 9:15 a.m. (PT) / 12:15 p.m. (ET) in Dana Point, California; and
- Jefferies 2nd Annual Healthcare Conference on Wednesday, June 25, 2008 at 12:30 p.m. (ET) in New York.
The presentations will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentations will be available. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Incyte's pipeline includes multiple compounds in Phase I and Phase II development for oncology, inflammation, diabetes and HIV. For additional information on Incyte, visit the Company's web site at www.incyte.com.
CONTACT:
Incyte Corporation
Pamela M. Murphy
Vice President
Investor Relations/Corporate Communications
302-498-6944
SOURCE: Incyte Corporation